Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy Y Feng

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|September 21, 2021
Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Plos One|December 8, 2022
Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virusSarah A Gilmore, Danny Tam, Tara L Cheung, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrugJoy Y Feng, Guofeng Cheng, Jason Perry, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)ValidationJulie Farand, Jeffrey E Kropf, Peter Blomgren, et al.
Science Translational Medicine|June 30, 2017
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronavirusesTimothy P Sheahan, Amy C Sims, Rachel L Graham, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable propertiesThorsten A Kirschberg, Sammy Metobo, Michael O Clarke, et al.
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Scientific Reports|February 23, 2023
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitroSheli R Radoshitzky, Patrick Iversen, Xianghan Lu, et al.
Journal of Medicinal Chemistry|January 27, 2017
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging VirusesDustin Siegel, Hon C Hui, Edward Doerffler, et al.
Cell Reports|July 16, 2020
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in MiceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|September 21, 2021
Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Plos One|December 8, 2022
Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virusSarah A Gilmore, Danny Tam, Tara L Cheung, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrugJoy Y Feng, Guofeng Cheng, Jason Perry, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)ValidationJulie Farand, Jeffrey E Kropf, Peter Blomgren, et al.
Science Translational Medicine|June 30, 2017
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronavirusesTimothy P Sheahan, Amy C Sims, Rachel L Graham, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable propertiesThorsten A Kirschberg, Sammy Metobo, Michael O Clarke, et al.
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Scientific Reports|February 23, 2023
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitroSheli R Radoshitzky, Patrick Iversen, Xianghan Lu, et al.
Journal of Medicinal Chemistry|January 27, 2017
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging VirusesDustin Siegel, Hon C Hui, Edward Doerffler, et al.
Cell Reports|July 16, 2020
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in MiceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Pageof 8